Evidence map›Paper›PMID 38334471›Full record

ArticleRadiology. Imaging cancer2024

Percutaneous Microwave Ablation for Treatment of Retroperitoneal Tumors.

Annika E Rossebo, Annie M Zlevor, Emily A Knott, Lu Mao, Allison B Couillard, Timothy J Ziemlewicz, J Louis Hinshaw, E Jason Abel, Meghan G Lubner, Erica M Knavel Koepsel and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology. Imaging cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Annika E RosseboFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0000-0001-9262-7502
Annie M ZlevorFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0000-0003-4990-9461
Emily A KnottFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).
Lu MaoFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0000-0002-8626-9822
Allison B CouillardFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).
Timothy J ZiemlewiczFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0000-0002-7033-1062
J Louis HinshawFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0009-0008-8517-1314
E Jason AbelFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).
Meghan G LubnerFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0000-0003-3788-2871
Erica M Knavel KoepselFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0000-0002-1772-8220
Shane A WellsFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).ORCID 0000-0002-1067-6624
Lindsay M StratchkoFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).
Paul F LaesekeFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).
Fred T LeeFrom the Departments of Radiology (A.E.R., A.M.Z., A.B.C., T.J.Z., J.L.H., E.J.A., M.G.L., E.M.K.K., S.A.W., L.M.S., P.F.L., F.T.L.), Biomedical Engineering (A.E.R., F.T.L.), Biostatistics and Medical Informatics (L.M.), and Urology (J.L.H., E.J.A., F.T.L.), University of Wisconsin-Madison School of Medicine and Public Health, 600 Highland Ave, E3/378 Clinical Science Center, Madison, WI 53792-3252; and Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (E.A.K.).
Anna Needs Neuroblastoma Answers · US

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
NCATS NIH HHS UL1 TR002373
6 · The paper itself

Abstract

Purpose To determine if microwave ablation (MWA) of retroperitoneal tumors can safely provide high rates of local tumor control. Materials and Methods This retrospective study included 19 patients (median age, 65 years [range = 46-78 years]; 13 [68.4%] men and six [31.6%] women) with 29 retroperitoneal tumors treated over 22 MWA procedures. Hydrodissection (0.9% saline with 2% iohexol) was injected in 17 of 22 (77.3%) procedures to protect nontarget anatomy. The primary outcomes evaluated were local tumor progression (LTP) and complication rates. Oncologic outcomes, including overall survival (OS), progression-free survival (PFS), and treatment-free interval (TFI), were examined as secondary outcome measures. Results Median follow-up was 18 months (range = 0.5-113). Hydrodissection was successful in displacing nontarget anatomy in 16 of 17 (94.1%) procedures. The LTP rate was 3.4% (one of 29; 95% CI: 0.1, 17.8) per tumor and 5.3% (one of 19; 95% CI: 0.1, 26.0) per patient. The overall complication rate per patient was 15.8% (three of 19), including two minor complications and one major complication. The OS rate at 1, 2, and 3 years was 81.8%, 81.8%, and 72.7%, respectively, with a median OS estimated at greater than 7 years. There was no evidence of a difference in OS (

Indexed as

Kidney NeoplasmsRetroperitoneal NeoplasmsAgedFemaleHumansMaleMicrowavesMiddle AgedRetrospective StudiesTreatment OutcomeAblation Techniques (ie, Radiofrequency, Thermal, Chemical)HydrodissectionMicrowave AblationRetroperitoneum

Identifiers

PMID38334471
PMCPMC10988338
OpenAlexW4391707157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.